Who are Ethinyl Estradiol + Cyproterone acetate's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): ethinyl estradiol and cyproterone acetate.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/ethinyl-estradiol-cyproterone-acetate.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Ethinyl Estradiol + Cyproterone acetate — Competitive Intelligence Brief

Ethinyl Estradiol + Cyproterone acetate (Ethinyl Estradiol + Cyproterone acetate) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Combined oral contraceptive with anti-androgenic activity. Area: Endocrinology / Gynecology.

marketed Combined oral contraceptive with anti-androgenic activity Androgen receptor (cyproterone acetate); estrogen receptor (ethinyl estradiol); gonadotropin suppression Endocrinology / Gynecology Small molecule Live · refreshed every 30 min

Target snapshot

Ethinyl Estradiol + Cyproterone acetate (Ethinyl Estradiol + Cyproterone acetate) — Fundação Educacional Serra dos Órgãos. Ethinyl estradiol suppresses gonadotropins while cyproterone acetate blocks androgen receptors, reducing androgenic effects in women.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Ethinyl Estradiol + Cyproterone acetate TARGET	Ethinyl Estradiol + Cyproterone acetate	Fundação Educacional Serra dos Órgãos	marketed	Combined oral contraceptive with anti-androgenic activity	Androgen receptor (cyproterone acetate); estrogen receptor (ethinyl estradiol); gonadotropin suppression
ethinyl estradiol and cyproterone acetate	ethinyl estradiol and cyproterone acetate	S.C.B. Medical College and Hospital	marketed	Combined oral contraceptive with anti-androgenic activity	Estrogen receptor, progesterone receptor, androgen receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Combined oral contraceptive with anti-androgenic activity class)

Fundação Educacional Serra dos Órgãos · 1 drug in this class
S.C.B. Medical College and Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Ethinyl Estradiol + Cyproterone acetate — Competitive Intelligence Brief. https://druglandscape.com/ci/ethinyl-estradiol-cyproterone-acetate. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab